Abbott's Earnings Made Easy

Abbott's Earnings Made Easy

This episode of The Motley Fool's Market Checkup dives into the hottest headlines and biggest market movers in the health-care sector and discusses an update on the implementation of the Affordable Care Act.

In this segment from the show, analysts David Williamson and Max Macaluso discuss health-care giant Abbott Laboratories . The company changed dramatically after spinning off its pharmaceutical division into AbbVie at the start of 2013. Today, shares of Abbott jumped 6.5% after the company reported its third-quarter results, but what was behind this surge? Could it be the news that Abbott is raising its dividend or its strong earnings? Tune in to find out key takeaways from the report.

Rock-solid dividend stocks
Dividend stocks can make you rich. It's as simple as that. While they don't garner the notoriety of high-flying growth stocks, they're also less likely to crash and burn. And over the long term, the compounding effect of the quarterly payouts, as well as their growth, adds up faster than most investors imagine. With this in mind, our analysts sat down to identify the absolute best of the best when it comes to rock-solid dividend stocks, drawing up a list in this free report of nine that fit the bill. To discover the identities of these companies before the rest of the market catches on, you can download this valuable free report by simply clicking here now.

The article Abbott's Earnings Made Easy originally appeared on

Alison Southwick, David Williamson, and Max Macaluso, Ph.D. have no position in any stocks mentioned. The Motley Fool recommends Baxter International. It recommends and owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Originally published